Grant: DANA-FARBER CANCER INSTITUTE, INC.
Primary Recipient
DANA-FARBER CANCER INSTITUTE, INC.
Amount
$1,061,795.00
Award Date
9/09/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Germinal center (GC) B-cell lymphomas are clinically and genetically heterogeneous disorders. The incidence of the most common GC B-cell lymphomas has increased dramatically in recent years, with a 50% rise in the last generation. The participants of this
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
IMMUNE DISEASE INSTITUTE, INC. | Sub-recipient | $413,280.00 |
DANA-FARBER CANCER INSTITUTE, INC. | Primary recipient | $347,334.00 |
BROAD INSTITUTE, INC., THE | Sub-recipient | $301,181.00 |